METTL14 reverses liver fibrosis by inhibiting NOVA2 through an m6A-YTHDF2-dependent mechanism.
Xiaoxue HouYuwen LiJiali SongLinya PengWen ZhangRui LiuHui YuanTiantong FengJieying LiWenting LiChuanlong ZhuPublished in: Hepatology communications (2023)
METTL14 functioned as a profibrotic gene by suppressing NOVA2 activity in a mechanism dependent on m6A-YTHDF2. Moreover, knocking down METTL14 exacerbated LF, while NOVA2 prevented its development and partly reversed the damage.